At a glance
- Originator Pharmacia Corporation
- Developer Nonindustrial source
- Class Anti-ischaemics; Antiallergics; Antiasthmatics; Antihyperglycaemics; Bronchodilators
- Mechanism of Action Antioxidants; Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic complications
Most Recent Events
- 23 Sep 1998 No-Development-Reported for Coronary disorders in Italy (Unknown route)
- 03 Aug 1998 No-Development-Reported for Diabetic complications in Italy (Unknown route)
- 20 Jan 1997 Preclinical development for Coronary disorders (Unknown route)